Return to PJ Online Home Page The Pharmaceutical Journal Vol 266 No 7133 p135
February 3, 2001

Leading Articles

Key to success
On guard


Key to success

Stopping smoking works. The risks of smoking are huge. Half of smokers are killed by their habit and many more develop cancer, heart disease, bronchitis, impaired fertility and other health problems as a consequence of smoking.

It is worth stopping smoking at any age, even after the onset of smoking-related illness. Quitting smoking is the single most important thing people can do for their health. The greatest benefits are seen in those quitting before middle age who then avoid most of the long-term risks. However, despite the widely known benefits, many people fail in attempts to give up the habit.

There is no doubt that quitting smoking is difficult. It needs preparation. An opportunity for smokers to quit is No Smoking Day which, this year, is on March 14 (p151). Informing smokers about No Smoking Day in the preceding month is vitally important. This will allow them time to prepare both physically and mentally for a quit attempt. Last year, half a million people in the United Kingdom tried to quit on No Smoking Day. Unfortunately, only a small percentage will have remained non-smokers today. If smokers are prepared for their quit attempt, it might just give them the edge, and that could mean the difference between success and failure.

Back to Top

On guard

Following the official launch of Levonelle this week, the Royal Pharmaceutical Society is echoing The Pharmaceutical Journal’s call last week for pharmacists to be on their guard when supplying non- prescription emergency hormonal contraception (see p137).

EHC remains high on the media’s agenda. Last week we reported how the Daily Mail had sent an under-age girl round pharmacies in London trying to buy it. The National Pharmaceutical Association is considering taking legal action over the resulting articles (see p139). This week attention has been focused on the sale of EHC over the internet by Superdrug.com. This development was mentioned unfavourably during the House of Lords debate on EHC on January 29 (see p136).

The Lords went on to reject a move to stop over-the-counter sales of EHC and their support is to be welcomed. But, as we said last week, pharmacists need to follow, and be seen to be following, the Society’s guidance if EHC through pharmacies is going to be judged a success.

Back to Top